• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康老龄化与阿尔茨海默病之间连续体中的经济决策:20 年研究的系统回顾。

Economic decision-making in the continuum between healthy aging and Alzheimer's Disease: A systematic review of 20 years of research.

机构信息

Laboratory of Neuropsychophysiology, Faculty of Psychology and Education Sciences, University of Porto, Portugal.

Laboratory of Neuropsychophysiology, Faculty of Psychology and Education Sciences, University of Porto, Portugal.

出版信息

Neurosci Biobehav Rev. 2021 Dec;131:1243-1263. doi: 10.1016/j.neubiorev.2021.10.030. Epub 2021 Oct 29.

DOI:10.1016/j.neubiorev.2021.10.030
PMID:34715151
Abstract

The effect of pathological aging on economic decision-making is a topic of major relevance as impairments in this domain place older adults at increased risk for financial abuse. This review aims to characterize decision-making across the continuum that goes from healthy aging to Alzheimer's Dementia. We included 42 studies comparing patients with Mild Cognitive Impairment (MCI) and healthy older adults, patients with Alzheimer's Disease (AD) and healthy older adults, and patients with MCI and patients with AD. Substantial evidence emerged suggesting that both MCI as AD affect economic decision-making. However, a non-negligible number of behavioural tasks failed to find significant differences between patients and controls, and no differences were reported between patients with MCI and AD. On the contrary, measures of financial capacity reached more robust findings, showing that healthy older adults had better performance than patients, while MCI patients showed better performance than AD patients. This review presents the main conclusions that may be drawn from significant findings, as well as the hypotheses and recommendations for future research.

摘要

病理性衰老对经济决策的影响是一个重大问题,因为在这一领域的损伤会使老年人面临更高的财务滥用风险。本综述旨在描述从健康衰老到阿尔茨海默病的连续体上的决策。我们纳入了 42 项研究,这些研究比较了轻度认知障碍(MCI)患者和健康老年人、阿尔茨海默病(AD)患者和健康老年人,以及 MCI 患者和 AD 患者。大量证据表明,MCI 和 AD 都会影响经济决策。然而,相当数量的行为任务没有发现患者和对照组之间的显著差异,也没有报告 MCI 患者和 AD 患者之间的差异。相反,财务能力的衡量标准得出了更有力的结论,表明健康老年人的表现优于患者,而 MCI 患者的表现优于 AD 患者。本综述介绍了从显著发现中可以得出的主要结论,以及未来研究的假设和建议。

相似文献

1
Economic decision-making in the continuum between healthy aging and Alzheimer's Disease: A systematic review of 20 years of research.健康老龄化与阿尔茨海默病之间连续体中的经济决策:20 年研究的系统回顾。
Neurosci Biobehav Rev. 2021 Dec;131:1243-1263. doi: 10.1016/j.neubiorev.2021.10.030. Epub 2021 Oct 29.
2
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
5
Galantamine for Alzheimer's disease.加兰他敏用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2002(3):CD001747. doi: 10.1002/14651858.CD001747.
6
Galantamine for Alzheimer's disease.加兰他敏用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2001(4):CD001747. doi: 10.1002/14651858.CD001747.
7
Nimodipine for primary degenerative, mixed and vascular dementia.尼莫地平用于原发性退行性、混合型和血管性痴呆。
Cochrane Database Syst Rev. 2001(1):CD000147. doi: 10.1002/14651858.CD000147.
8
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
9
Folic acid with or without vitamin B12 for cognition and dementia.叶酸联合或不联合维生素B12对认知及痴呆的影响
Cochrane Database Syst Rev. 2003(4):CD004514. doi: 10.1002/14651858.CD004514.
10
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.

引用本文的文献

1
Attenuated neural activity in processing decision-making feedback in uncertain conditions in patients with mild cognitive impairment.轻度认知障碍患者在不确定条件下处理决策反馈时神经活动减弱。
Eur Arch Psychiatry Clin Neurosci. 2024 Jun 25. doi: 10.1007/s00406-024-01793-0.
2
Metacognitive Strategy Training Improves Decision-Making Abilities in Amnestic Mild Cognitive Impairment.元认知策略训练可提高遗忘型轻度认知障碍患者的决策能力。
J Intell. 2023 Sep 11;11(9):182. doi: 10.3390/jintelligence11090182.
3
Mild Cognitive Impairment is Associated with Poorer Everyday Decision Making.
轻度认知障碍与较差的日常决策能力相关。
J Alzheimers Dis. 2023;94(4):1607-1615. doi: 10.3233/JAD-230222.